Wellington Management Group
XFOR icon

Wellington Management Group’s X4 Pharmaceuticals XFOR Stock Holding History

Wellington Management Group’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$242K Buy
+51,800
New +$213K ﹤0.01% 1883

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group's XFOR Position: Q2 2026 in Review

Wellington Management Group opened a new position in X4 Pharmaceuticals (XFOR) in Q2 2026: 51,800 shares worth $242K. The stake represents ﹤0.01% of the portfolio and ranks #1883 among its holdings.

89 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

  • Wellington Management Group held 51,800 shares of X4 Pharmaceuticals worth $242K as of Q2 2026.
  • X4 Pharmaceuticals was a new Wellington Management Group position in Q2 2026.
  • X4 Pharmaceuticals made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1883 holding.
  • 89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.